Skip to Content
Morningstar

Cencora Inc COR

Morningstar Rating
Unlock
Stock XNYS Rating as of
$232.23 +2.09 (0.91%)
View Full Chart
As of Delayed Price Post-Trading: $232.23 0.00
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Cencora Sees Margin Improvement From Favorable Mix and Drug Pricing Trend

Keonhee Kim

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $200 billion in annual US healthcare distribution sales, the company supplies roughly one third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Read Full Report

Price vs Fair Value

View History
COR is trading within a range we consider fairly valued.
Price
$230.14
Fair Value
$941.00
Uncertainty
Medium
1-Star Price
$844.40
5-Star Price
$511.50
Economic Moat
Rndhvz
Capital Allocation
Gksfghp

Bulls Say, Bears Say

Bulls

Cencora distributes pharmaceutical products to nearly one third of the industry, leading to substantial negotiation leverage with generic drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COR is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$230.14
Day Range
$227.56–232.62
52-Week Range
$171.65–246.75
Bid/Ask
$205.00 / $232.80
Market Cap
$45.73 Bil
Volume/Avg
863,716 / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
17.90
Price/Sales
0.17
Dividend Yield (Trailing)
0.87%
Dividend Yield (Forward)
0.88%
Total Yield
2.63%

Company Profile

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
46,000
Website
https://www.cencora.com

Competitors

Valuation

View More
Metric
COR
MCK
CAH
Price/Earnings (Normalized)
 17.9021.5613.79
Price/Book Value
 42.36——
Price/Sales
 0.170.260.11
Price/Cash Flow
 14.2918.1110.23
Price/Earnings
COR
MCK
CAH

Financial Strength

Metric
COR
MCK
CAH
Quick Ratio
 0.500.500.43
Current Ratio
 0.890.920.98
Interest Coverage
 9.1015.5718.37
Quick Ratio
COR
MCK
CAH

Profitability

Metric
COR
MCK
CAH
Return on Assets (Normalized)
 4.19%5.63%4.01%
Return on Equity (Normalized)
 373.63%——
Return on Invested Capital (Normalized)
 47.73%64.13%97.71%
Return on Assets
COR
MCK
CAH
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Distribution Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
CmnphtrtwRrsthq$76.9 Bil
 Cardinal Health Inc
CAH
YcjplwfmYbwrmb$24.1 Bil
 Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
—Ygbnsfx$8.7 Bil
 Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
—Xlkpqg$8.7 Bil
 Sinopharm Group Co Ltd ADR
SHTDY
—Cnkkmrk$8.7 Bil
 Sinopharm Group Co Ltd
SHTDF
—Trwdxnh$8.7 Bil
 Amplifon SpA Az nom Post Frazionamento
AMFPF
—Xnwsn$8.4 Bil
 Medipal Holdings Corp ADR
MAHLY
—Qbqf$3.1 Bil
 Medipal Holdings Corp
MEPDF
—Qrvqd$3.1 Bil

Sponsor Center